Year-end Sale % OFF 
Abstract
BackgroundSubclinical hypothyroidism (SH) is defined as serum levels of thyroid-stimulating hormone (TSH) above the upper limit with normal concentrations of free T4 (fT4). Its management remains challenging. The aim of the study was to evaluate clinical and laboratory findings as well as the clinical course of children with SH followed in a third level hospital. Sixty-five patients aged between 2 and 18 years old were retrospectively studied.MethodsThe patients were followed for a median period of 9 months (range 6 months to 24 months). Those who normalized TSH levels were discharged (Group 1). If TSH persisted mildly elevated (5-10μUI/mL) with normal fT4 and negative TPOAb/TgAb, they were classified as Group 2 and followed semi-annually without treatment. Those patients whose TSH raised ≥10μUI/mL or who maintained TSH 5-10μUI/mL and positive TPOAb/TgAb were considered suitable for thyroxin therapy (Group 3, G3).ResultsIn 89% of our patients, TSH concentrations spontaneously reverted to normality or remained stable without treatment (Groups 1 and 2), whereas less than 11% progressed to clinical hypothyroidism (Group 3). Baseline TSH was significantly lower in group 1 than in group 3. In group 3 the prevalence of female sex (71%) was higher and TPO antibodies were present in 85% of patients. The risk of developing overt hypothyroidism in patients with positive anti-thyroid antibodies respect to those who normalized TSH was 45 (95%CI 6.5–312.5).ConclusionBaseline TSH, female sex and the presence of thyroid autoimmunity were the best predictors of the evolution to SH over time.
Highlights
Subclinical hypothyroidism (SH) is defined as serum levels of thyroid-stimulating hormone (TSH) above the upper limit with normal concentrations of free T4
Idiopathic SH is characterized by mild elevations of TSH concentrations levels (5-10μUI/mL) with peripheral hormones free T4 (fT4) and triiodothyronine within normal ranges, absence of thyroid autoimmunity or other conditions that may account for the increase in TSH, such as certain medications or genetic disorders (Down syndrome, Pseudohypoparathyroidism and others), and without clinical signs or symptoms of thyroid failure
There is a lack of conclusive studies that determine whether these children with SH might benefit from levothyroxine treatment [7,8,9]
Summary
Subclinical hypothyroidism (SH) is defined as serum levels of thyroid-stimulating hormone (TSH) above the upper limit with normal concentrations of free T4 (fT4). Subclinical hypothyroidism (SH), known as isolated hyperthyrotropinemia, is defined as serum thyroidstimulating hormone (TSH) concentrations above the upper limit of the reference range and normal concentrations of free T4 (fT4). This situation occurs in less than 3% of children and adolescents [1, 2], but it is a cause of concern for parents and primary care physicians. There is a lack of conclusive studies that determine whether these children with SH might benefit from levothyroxine treatment [7,8,9]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
